Answers are grounded in this paper and cite their sources.
The electrochemical properties of a Prussian blue (PB) electrode were improved by introducing cetyltrimethylammonium bromide (CTAB) and Au nanoparticles (AuNPs) into PB films. The novel hybrid films (PB/CTAB/AuNPs) were fabricated by electrodepositing PB and AuNPs in the presence of CTAB. The electrochemical behavior of the hybrid film in some supporting electrolyte (cations for the K +, Na +, or K + /Na + ) was investigated in detail, and well-defined and reversible voltammetric responses were obtained in Na + -based electrolytes. The catalytic activity of the PB/CTAB/AuNPs electrode toward hydrogen peroxide (H 2 O 2 ) reduction at a neutral pH was also investigated, and the results indicated that the electrochemical reduction of H 2 O 2 in the presence of physiological levels of Na + was superior to that of a PB-modified electrode. Moreover, the PB/CTAB/AuNPs electrode exhibited good performance, a low detection limit (0.1 μM), and high stability at a wide range of concentrations (0.882−195 μM). To determine the performance of PB nanocomposite electrodes in Na + -based phosphate buffers, an amperometric biosensor with a PB/CTAB/AuNPs electrocatalyst was developed. To fabricate this sensor, the enzyme was immobilized in sol−gel and was electrodeposited onto a PB nanocomposite film. The results indicated that the biosensor can be used at a wide range of concentrations (20−400 μM) and possesses a low detection limit (7 μM) for glucose. These characteristics demonstrate that PB nanocomposite film can be used as an electron mediator for biosensors in potassium-free phosphate buffers.
No takes yet. Share an insight, caveat, or question.
Du et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: